Compounds > homocystine
Page last updated: 2024-08-21

homocystine and Thrombophilia

homocystine has been researched along with Thrombophilia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battaglioli, T; Cattaneo, M; Mannucci, PM; Martinelli, I; Pedotti, P1
Jagroop, IA; Mikhailidis, DP; Mohan, IV; Stansby, GP1
Bernardi, F; Coccheri, S; Ferraresi, P; Grauso, F; Grossi, G; Legnani, C; Marchetti, G; Palareti, G; Piazzi, S; Sassi, S1

Other Studies

3 other study(ies) available for homocystine and Thrombophilia

ArticleYear
Hyperhomocysteinemia in cerebral vein thrombosis.
    Blood, 2003, Aug-15, Volume: 102, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Child; Female; Folic Acid; Homocystine; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors; Thrombophilia; Venous Thrombosis; Vitamin B 12

2003
Homocysteine activates platelets in vitro.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2008, Volume: 14, Issue:1

    Topics: Case-Control Studies; Extremities; Female; Homocystine; Humans; Ischemia; Male; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombophilia; Thrombosis

2008
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Adult; Aged; Antithrombin III; Antithrombin III Deficiency; Disease Susceptibility; Enzyme Activation; Factor V; Gene Frequency; Genotype; Homocysteine; Homocystine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Protein C; Protein S Deficiency; Risk Factors; Thrombophilia

1997